Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

evolocumab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lung Cancer Metastatic × evolocumab × Clear all

NCT05144529 2026-05-05

TOP2101

Duke University

Phase 2 Terminated

19 enrolled 16 charts

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡